PubMed:30592011 / 239-360 JSONTXT

{"project":"PubMed_ArguminSci","denotations":[{"id":"T2","span":{"begin":0,"end":121},"obj":"DRI_Background"}],"text":"Most pathogenic LRRK2 mutations display increased kinase activity, which is believed to underlie LRRK2-mediated toxicity."}